Condyloma Acuminata
📧 Sign up to get email alerts when something new happens for Condyloma Acuminata.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-11-22FDA Approved: PODOFILOX — Original Application (Padagis US LLC)
FDA approved Padagis US LLC's Podofilox (podofilox) topical solution from an original ANDA for treating external genital warts caused by HPV…
-
FDA approval · 2016-07-08FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Veregen (sinecatechins) submitted by ANI Pharmaceuticals, Inc., indicating approval of the r…
-
FDA approval · 2013-05-09FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Veregen (sinecatechins) submitted by ANI Pharmaceuticals, Inc. The action relates to the already…
-
FDA approval · 2012-11-19FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Veregen (sinecatechins) submitted by ANI Pharmaceuticals, Inc., effectively updating/expandi…
-
FDA approval · 2008-02-13FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Veregen (sinecatechins) submitted by ANI Pharmaceuticals, Inc. The supplemental action relates t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-12-19FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for VEREGEN (sinecatechins) filed by ANI Pharmaceuticals, Inc.
-
FDA approval · 2007-06-27FDA Approved: VEREGEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Veregen (sinecatechin) submitted by ANI Pharmaceuticals.